Literature DB >> 20874426

Heart irradiation as a risk factor for radiation pneumonitis.

Ellen X Huang1, Andrew J Hope, Patricia E Lindsay, Marco Trovo, Issam El Naqa, Joseph O Deasy, Jeffrey D Bradley.   

Abstract

PURPOSE: to investigate the potential role of incidental heart irradiation on the risk of radiation pneumonitis (RP) for patients receiving definitive radiation therapy for non-small-cell lung cancer (NSCLC).
MATERIAL AND METHODS: two hundred and nine patient datasets were available for this study. Heart and lung dose-volume parameters were extracted for modeling, based on Monte Carlo-based heterogeneity corrected dose distributions. Clinical variables tested included age, gender, chemotherapy, pre-treatment weight-loss, performance status, and smoking history. The risk of RP was modeled using logistic regression.
RESULTS: the most significant univariate variables were heart related, such as heart heart V65 (percent volume receiving at least 65 Gy) (Spearman Rs = 0.245, p < 0.001). The best-performing logistic regression model included heart D10 (minimum dose to the hottest 10% of the heart), lung D35, and maximum lung dose (Spearman Rs = 0.268, p < 0.0001). When classified by predicted risk, the RP incidence ratio between the most and least risky 1/3 of treatments was 4.8. The improvement in risk modeling using lung and heart variables was better than using lung variables alone.
CONCLUSIONS: these results suggest a previously unsuspected role of heart irradiation in many cases of RP.

Entities:  

Mesh:

Year:  2010        PMID: 20874426      PMCID: PMC4041523          DOI: 10.3109/0284186X.2010.521192

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  37 in total

1.  Quantification of radiation-induced regional lung injury with perfusion imaging.

Authors:  L B Marks; M T Munley; D P Spencer; G W Sherouse; G C Bentel; J Hoppenworth; M Chew; R J Jaszczak; R E Coleman; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

2.  Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results.

Authors:  M P Sunyach; L Falchero; P Pommier; M Perol; D Arpin; M Vincent; D Boutry; P Rebatu; C Ginestet; I Martel-Lafay; D Perol; C Carrie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-09-01       Impact factor: 7.038

3.  Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.

Authors:  B J Brooks; E J Seifter; T E Walsh; A S Lichter; P A Bunn; A Zabell; A Johnston-Early; M Edison; R W Makuch; M H Cohen
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

4.  Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.

Authors:  T J Robnett; M Machtay; E F Vines; M G McKenna; K M Algazy; W G McKenna
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

5.  Reporting and analyzing dose distributions: a concept of equivalent uniform dose.

Authors:  A Niemierko
Journal:  Med Phys       Date:  1997-01       Impact factor: 4.071

6.  A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis.

Authors:  P Rubin; C J Johnston; J P Williams; S McDonald; J N Finkelstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

7.  Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.

Authors:  Tiziana Rancati; Giovanni Luca Ceresoli; Giovanna Gagliardi; Stefano Schipani; Giovanni Mauro Cattaneo
Journal:  Radiother Oncol       Date:  2003-06       Impact factor: 6.280

8.  A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.

Authors:  Line Claude; David Pérol; Chantal Ginestet; Lionel Falchero; Dominique Arpin; Michel Vincent; Isabelle Martel; Stéphane Hominal; Jean-François Cordier; Christian Carrie
Journal:  Radiother Oncol       Date:  2004-05       Impact factor: 6.280

9.  Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.

Authors:  Yvette Seppenwoolde; Katrien De Jaeger; Liesbeth J Boersma; José S A Belderbos; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

10.  The effect of irradiation on lung function and perfusion in patients with lung cancer.

Authors:  R P Abratt; P A Willcox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-02-15       Impact factor: 7.038

View more
  41 in total

Review 1.  Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.

Authors:  Joshua D Palmer; Nicholas G Zaorsky; Matthew Witek; Bo Lu
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer.

Authors:  Yevgeniy Vinogradskiy; Quentin Diot; Bernard Jones; Richard Castillo; Edward Castillo; Jennifer Kwak; Daniel Bowles; Inga Grills; Nicholas Myziuk; Thomas Guerrero; Craig Stevens; Tracey Schefter; Laurie E Gaspar; Brian Kavanagh; Moyed Miften; Chad Rusthoven
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-23       Impact factor: 7.038

3.  Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancers.

Authors:  Katrina Woodford; Vanessa Panettieri; Jeremy D Ruben; Sashendra Senthi
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

4.  Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.

Authors:  Jose L Lopez Guerra; Daniel R Gomez; Yan Zhuang; Lawrence B Levy; George Eapen; Hongmei Liu; Radhe Mohan; Ritsuko Komaki; James D Cox; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-13       Impact factor: 7.038

Review 5.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

6.  Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

Authors:  Nicki Groom; Elena Wilson; Corinne Faivre-Finn
Journal:  Br J Radiol       Date:  2017-03-31       Impact factor: 3.039

7.  Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.

Authors:  M Thor; Jo Deasy; A Iyer; E Bendau; A Fontanella; A Apte; E Yorke; A Rimner; A Jackson
Journal:  Radiother Oncol       Date:  2019-05-27       Impact factor: 6.280

8.  IPW-5371 Proves Effective as a Radiation Countermeasure by Mitigating Radiation-Induced Late Effects.

Authors:  Christopher Rabender; Eleonora Mezzaroma; Adolfo G Mauro; Ramesh Mullangi; Antonio Abbate; Mitchell Anscher; Barry Hart; Ross Mikkelsen
Journal:  Radiat Res       Date:  2016-11       Impact factor: 2.841

9.  Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.

Authors:  Ellen D Yorke; Andrew Jackson; Li Cheng Kuo; Anthonia Ojo; Kelly Panchoo; Prasad Adusumilli; Marjorie G Zauderer; Valerie W Rusch; Annemarie Shepherd; Andreas Rimner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-27       Impact factor: 7.038

10.  Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience.

Authors:  Pierluigi Bonomo; Lorenzo Livi; Andrea Rampini; Icro Meattini; Benedetta Agresti; Gabriele Simontacchi; Fabiola Paiar; Monica Mangoni; Ivano Bonucci; Daniela Greto; Laura Masi; Raffaella Doro; Livia Marrazzo; Giampaolo Biti
Journal:  Radiol Med       Date:  2013-05-28       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.